Medical progress - Risks of testosterone-replacement therapy and recommendations for monitoring

被引:482
作者
Rhoden, EL
Morgentaler, A
机构
[1] Beth Israel Deaconess Med Ctr, Div Urol, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
关键词
D O I
10.1056/NEJMra022251
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:482 / 492
页数:11
相关论文
共 72 条
[1]  
ANDERSON RA, 1995, THROMB HAEMOSTASIS, V74, P693
[2]   Drug therapy - Androgens in men - Uses and abuses [J].
Bagatell, CJ ;
Bremner, WJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (11) :707-714
[3]  
BARRETTCONNOR EL, 1995, DIABETES METAB, V21, P156
[4]   Risks versus benefits of testosterone therapy in elderly men [J].
Basaria, S ;
Dobs, AS .
DRUGS & AGING, 1999, 15 (02) :131-142
[5]  
Bhasin S, 2003, J ANDROL, V24, P299
[6]   Emerging issues in androgen replacement therapy [J].
Bhasin, S ;
Bremner, WJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (01) :3-8
[7]  
Bhasin S, 2001, J ANDROL, V22, P718
[8]   MULTIPLE HEPATIC ADENOMAS AFTER LONG-TERM THERAPY WITH TESTOSTERONE ENANTHATE - REVIEW OF THE LITERATURE [J].
CARRASCO, D ;
PRIETO, M ;
PALLARDO, L ;
MOLL, JL ;
CRUZ, JM ;
MUNOZ, C ;
BERENGUER, J .
JOURNAL OF HEPATOLOGY, 1985, 1 (06) :573-578
[9]   LONGITUDINAL EVALUATION OF SERUM ANDROGEN LEVELS IN MEN WITH AND WITHOUT PROSTATE-CANCER [J].
CARTER, HB ;
PEARSON, JD ;
METTER, EJ ;
CHAN, DW ;
ANDRES, R ;
FOZARD, JL ;
ROSNER, W ;
WALSH, PC .
PROSTATE, 1995, 27 (01) :25-31
[10]   PROSTATE-SPECIFIC ANTIGEN VARIABILITY IN MEN WITHOUT PROSTATE-CANCER - EFFECT OF SAMPLING INTERVAL ON PROSTATE-SPECIFIC ANTIGEN VELOCITY [J].
CARTER, HB ;
PEARSON, JD ;
WACLAWIW, Z ;
METTER, EJ ;
CHAN, DW ;
GUESS, HA ;
WALSH, PC .
UROLOGY, 1995, 45 (04) :591-596